Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2005-06-08
2009-12-15
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C552S574000, C552S576000, C552S577000
Reexamination Certificate
active
07632826
ABSTRACT:
Corticosteroid receptors and/or mineralo-corticoid receptors are administered in combination with an addictive drug or the pharmacodynamic equivalent thereof for the therapy of an addictive disease triggered by said addictive drug or connected thereto.
REFERENCES:
patent: WO 97/03677 (1997-02-01), None
patent: WO 98/42275 (1998-10-01), None
Mantsch et al., “Corticosterone Facilitates the Acquisition of Cocaine Self-Administration in Rats: Opposite Effects of the Type II Glucocorticoid Receptor Agonist Dexamethasone” The Journal of Pharmacology and Experimental Therapeutics (1998) vol. 287, No. 1, pp. 72-80.
Montgomery, S° P. and Dafny, N. Cyclophosphamide and cortisol reduce the severity of morphine withdrawal. Int. J. Immunopharmacol. (1987) vol. 9, pp. 453-457.
Capasso, A. et al. “Dexamethasone pretreatment redu˜s the psychomotor stimulant effects induced by cocaine and amphetamine in mice” Prog. Neuropsvchopharmacol. & Biol. Psychiat. (1995) vol. 19, pp. 1063-1079.
Albrecht, K., et al., “Diagnostik und Therapie von akuten Drogennotfallen,”Z. arztt Fortbild., 85:701-707 (1992).
Capasso, A. et al., “Dexamethasone pretreatment reduces the psychomotor stimulant effects induced by cocaine and amphetamine in mice,”Prog. Neuro-psychopharmacol. & Biol. Psychiat., 19:1063-1079 (1995).
Capasso, A. et al., “Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues,”J. Pharmacot Exp. Therapeut., 276:743-751(1996).
Capasso, A. et al., “Dexamethasone inhibition of acute opioid physical dependence in vitro is reverted by anti-lipocortin-1 and mimicked by anti-type II extracellular PLA2 antibodies,”Life Sci., 61:127-134 (1997).
Ehrenreich, H. et al., “OLITA: an alternative in the treatment of therapy-resistant chronic alcoholics,”Eur. Arch Psychiatry Clin. Neurosci., 247:51-54(1997).
Mantsch, J.R. et al., “Corticosterone facilitates the acquisition of cocaine self-administration in rats: opposite effects of the type ll glucocorticoid receptor agonist dexamethasone,”J. Pharmacol. Exp. Therapeut, 287:72-80 (1998).
Montgomery, S.P., et al. “Cyclophosphamide and cortisol reduce the severity of morphine withdrawal”Int J. Immunopharmacol., 9:453-457 (1987).
Reddy, D.S., et al., “Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice,”Methods Find Exp Clin Pharmacol, 19:395-405 (1997).
Sass, H. et al. “Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence,”Arch. Gen. Psychiatry, 53:673-680 (1996).
Sze, P.Y., “The permissive role of glucocorticoids in the development of ethanol dependence and tolerance,”J. Drug Alcohol Dep., 2:381-396 (1977).
Whitworth, A.B. et al., “Comparison of acamprosate and placebo in longterm treatment of alcohol dependence,”Lancet, 347:1438-1442 (1996).
Caggiula et al., “The role of corticosteroids in nicotine's physiological and behavioral effects,” Psychoneuroendocrinology, 22:143-159 (1998).
Hardman et al.,Goodman & Gilman's the Pharmacological Basis of Therapeutics, 9th Ed., p. 51 (1996).
Brecht, J. G., et al., “Alcoholism:The cost of illness in the Federal Republic of Germany”PharmacoEconomics, 10:484-493 (1996).
Heyne, A.,“The development of opiate addiction in the rat,”PharmacoL Biochem. Behav., 53:11-25 (1996).
Roch, I., et al., “Empirische Ergebnisse zum Therapieabbruch bei Drogenabhangigen: ein. LiteraturUberblick,”Sucht, 38:305-322 (1992).
Schmidt, L.G., et al., “Relapse Prevention in alcoholics with an anticraving drug treatment: first results of the Berlin study,”.Pharmacopsychiatry, 27:21-23 (1996).
Sobell, L.C., et al., “What triggers the resolution of alcohol problems without treatment?”Alcohol. Clin. Exp. Res., 17:217-224 (1993).
Süss . H. M., “Zur Wirksamkeit der Therapie bei Alkoholabhangigen: Ergebnisse einer Meta-Analyse,”.Psychol Rundschau, 46:248-266 (1995).
Wolffgramm, J., “Abhangigkeitsentwicklung in Tiermodell,”Z. Klin. Psychol., 24:107-117 (1995).
Wolffgramm, J., et al., “From controlled drug intake to loss of control: the irreversible development of drug addiction in the rat,”Behav. Brain Res., 70:77-94 (1995).
Curamentis Ltd.
Haley Jr. James F.
Jiang Shaojia Anna
Mangasarian Karen
Olson Eric S
LandOfFree
Use of agonists of the glucocorticosteroid and/or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of agonists of the glucocorticosteroid and/or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of agonists of the glucocorticosteroid and/or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4124090